When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Late-stage specialty pharma company advancing drug candidates for rare and orphan diseases, Acasti Pharma ( NASDAQ: ACST ) appoints Prashant Kohli as CEO, succeeding Jan D'Alvise.
The parties have mutually agreed to part ways, and Ms. D'Alvise will be stepping down from the board.
Prashant Kohli has served as Chief Commercial Officer of Acasti since 2022 and has over 20 years of commercialization experience leading strategy, sales, marketing, and product management.